Published in Surg Today on March 23, 2011
Functional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer. Front Genet (2013) 0.78
Predictive potential role of glutathione S-transferases polymorphisms on prognosis of breast cancer. Int J Clin Exp Pathol (2014) 0.77
Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control (2013) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol (1995) 10.39
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J (1994) 3.81
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76
The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer (2005) 2.69
Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev (1997) 2.32
Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst (1998) 1.97
Prediction of docetaxel response in human breast cancer by gene expression profiling. J Clin Oncol (2005) 1.73
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer (2003) 1.50
Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet (2006) 1.26
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer. J Clin Oncol (2005) 1.23
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response. Eur J Cancer (2003) 1.14
Gene deletion and partial deficiency of the glutathione S-transferase (ligandin) system in man. FEBS Lett (1981) 1.13
Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer (2005) 1.08
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. J Transl Med (2007) 1.00
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol (2008) 0.99
Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan. Clin Chim Acta (2006) 0.94
Pharmacogenetics in the treatment of breast cancer. Pharmacogenomics J (2004) 0.91
Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer. Breast Cancer (2005) 0.90
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res (1999) 0.88
Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer. Breast Cancer Res (1999) 0.86
Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy. J Egypt Natl Canc Inst (2006) 0.82
Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer (2007) 0.81
Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev (2004) 0.81
Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma. Cancer (1996) 0.80
Neo-adjuvant therapy in breast cancer. Ann Oncol (2005) 0.80
Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev (2006) 0.77
Breast cancer and neoadjuvant therapy: any predictive marker? Neoplasma (2004) 0.75
Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods (2010) 2.77
Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Antimicrob Agents Chemother (2006) 1.02
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob Agents Chemother (2011) 0.99
Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals. FEBS J (2011) 0.91
Pharmacokinetics of intravenously administered azithromycin in pediatric patients. Pediatr Infect Dis J (2005) 0.89
Placental lead-induced oxidative stress and preterm delivery. Environ Toxicol Pharmacol (2008) 0.85
Novel tripod amphiphiles for membrane protein analysis. Chemistry (2013) 0.81
Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res (2007) 0.81
Glutathione-S-transferase M1 and T1 genes and gastric cancer: a case control study in North Indian population. Gene (2011) 0.79
An estimation and evaluation of total antioxidant capacity of saliva in children with severe early childhood caries. Int J Paediatr Dent (2011) 0.79
Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients. Mol Cell Biochem (2009) 0.78
Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population. Mol Biol Rep (2012) 0.78
Pediatric and adolescent pheochromocytoma: clinical presentation and outcome of surgery. Indian Pediatr (2014) 0.77
Hypertriglyceridemia and megacystis-microcolon-intestinal hypoperistalsis syndrome. J Pediatr Gastroenterol Nutr (2008) 0.75
Hypocalcemia and parathyroid hormone assay. World J Surg (2007) 0.75
Influence of a 3-day regimen of azithromycin on the disposition kinetics of cyclosporine A in stable renal transplant patients. Pharmacol Res (2003) 0.75
Azithromycin and the risk of cardiovascular death. N Engl J Med (2012) 0.75
Response to "Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience" (Int J Radiat Oncol Biol Phys 2009;73:795-801). Int J Radiat Oncol Biol Phys (2010) 0.75
Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules. Pharm Res (2011) 0.75